Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Replicor drug demonstrates potential against influenza strains
REP 9 has potent activity against influenza when given either in prophylaxis or as therapy. In tissue culture, REP 9 showed potent activity against over 10 strains of
REP 9 has potent activity against influenza when given either in prophylaxis or as therapy. In tissue culture, REP 9 showed potent activity against over 10 strains of
Roche currently markets daclizumab for induction transplant therapy as Zenapax. Roche and Protein are developing a new subcutaneous daclizumab (daclizumab s.c.) formulation for use in phase II clinical
The crossover study compared the pharmacokinetics between equal strengths of BioDelivery Sciences’s (BDSI’s) oral adhesive disc (called Bema Fentanyl) and Actiq, a lozenge formulation of fentanyl. The study
The trial will be conducted at multiple centers in the US and will compare Heplisav to GlaxoSmithKline’s Engerix-B vaccine. The trial is designed to yield safety, tolerability, pharmacokinetic
The phase II trial, conducted in Germany, was an open-label study to evaluate the efficacy, safety and tolerability of HGS-ETR1 (mapatumumab) as monotherapy in patients with relapsed or
Biolex is co-developing Locteron in collaboration with drug delivery and development company OctoPlus, initially for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a recombinant
DepoBupivacaine is SkyePharma’s novel sustained-release injectable formulation of the local anaesthetic bupivacaine and is designed to provide localized pain relief for more than 48 hours after a surgical
Following clearance, Alnylam plans to initiate a phase I safety study in healthy adult volunteers, representing the first program the company will have advanced to human clinical trials.
AGS-PSCA is a fully human monoclonal antibody directed to Agensys’ proprietary target prostate stem cell antigen (PSCA), an antigen expressed at significant levels on tumor cells from the
Additionally, there will be no refrigeration requirements for the tablets, benefits not available with the old Kaletra capsules. The FDA approval of the Kaletra tablet formulation was based